(Q45865539)

17 December 2017

title

Congenital muscular dystrophy: mini-agrin delivers in mice (English)

1 reference

17 December 2017

congenital muscular dystrophy

main subject

1 reference

Meinen S

1

1 reference

17 December 2017

Ruegg MA

series ordinal

2

1 reference

17 December 2017

publication date

1 June 2006

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

13

1 reference

17 December 2017

issue

11

1 reference

17 December 2017

page(s)

869-870

1 reference

17 December 2017

Amelioration of laminin-alpha2-deficient congenital muscular dystrophy by somatic gene transfer of miniagrin

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302668

7 January 2021

An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302668

7 January 2021

Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-alpha2-deficient mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302668

7 January 2021

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302668

7 January 2021

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302668

7 January 2021

Systemic delivery of genes to striated muscles using adeno-associated viral vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302668

7 January 2021

Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302668

7 January 2021

New insights into the roles of agrin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302668

7 January 2021

Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302668

7 January 2021

Muscle-specific BCL2 expression ameliorates muscle disease in laminin {alpha}2-deficient, but not in dystrophin-deficient, mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302668

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302668

1 reference

17 December 2017

Dimensions Publication ID

1027214993

0 references

1 reference

17 December 2017